Fisher & Paykel Healthcare Board Chair Scott St John has announced his intention to retire from the Board with effect from the close of the company's annual shareholders' meeting in August this year. The Board has elected current director Neville Mitchell to succeed Mr. St John as Chair. Mr. St John has held the role of Chair since August 2020 after joining the Board in 2015.

It is generally expected that the company's non-executive directors will serve for a total period, including re-elections, of approximately nine years. Mr. St John has led the Board during a transformational period for the company. Under his leadership, Fisher & Paykel Healthcare supplied products that helped millions of patients during the pandemic, purchased land for a second New Zealand campus and expanded its manufacturing footprint in Mexico and China.

Mr. Mitchell joined the Board of Fisher & Paykel Healthcare in November 2018 as an independent director. From 1995 to 2017, he was the Chief Financial Officer and Company Secretary of Cochlear, a global leader in implantable hearing solutions, and he played a key role in the company's financial management and global expansion. He is currently a non-executive director of Sonic Healthcare and Sigma Healthcare, and is a former director of The Board of Tax, South Eastern Sydney Local Health District, Osprey Medical and Sirtex Medical.

Mr. Mitchell said it would be a privilege to lead the Board of Directors following Mr. St John's retirement. The Board will commence a search to find a replacement director for Mr. St John with the skills and experience to complement other members of the Board. Mr. St John's outstanding contribution to Fisher & Paykel Healthcare will be formally acknowledged at the annual shareholders' meeting in August.